Back to top

GRI Bio (GRI) Reports Promising Interim Results from Phase 2a Study on IPF

GRI Bio (GRI) Reports Promising Interim Results from Phase 2a Study on IPF

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GRI Bio, Inc. (GRI)